Global, regional, and national burden of other musculoskeletal disorders 1990–2017: results from the Global Burden of Disease Study 2017
Autor: | Damian G Hoy, Jay S. Kaufman, Kristin Carson-Chahhoud, Lyn March, Amir Almasi-Hashiani, Ahad Ashrafi-Asgarabad, Mahdi Sepidarkish, Ali-Asghar Kolahi, Anthony D. Woolf, Saeid Safiri, Emma Smith, Marita Cross, Mohammad Ali Mansournia, Gary S. Collins |
---|---|
Přispěvatelé: | Safiri, S, Kolahi, AA, Cross, Marita, Carson-Chahhoud, K, Almasi-Hashiani, A, Kaufman, Jay, Mansournia, Mohammad Ali, Sepidarkish, Mahdi, Ashrafi-Asgarabad, Ahad, Hoy, Damian, Collins, Gary, Woolf, Anthony D, March, Lyn, Smith, Emma |
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty prevalence Population Prevalence Psychological intervention Global Health Global Burden of Disease burden Life Expectancy systemic lupus erythematosus Rheumatology Risk Factors Epidemiology Humans Medicine Disability-adjusted life year Disabled Persons Pharmacology (medical) Musculoskeletal Diseases joint diseases education education.field_of_study Neck pain business.industry Incidence Incidence (epidemiology) osteomyelitis Middle Aged Low back pain Socioeconomic Factors incidence other musculoskeletal disorders Female epidemiology Quality-Adjusted Life Years medicine.symptom business Demography |
Zdroj: | Rheumatology. 60:855-865 |
ISSN: | 1462-0332 1462-0324 |
DOI: | 10.1093/rheumatology/keaa315 |
Popis: | Objectives To describe the level and trends of point prevalence, deaths and disability-adjusted life years (DALYs) for other musculoskeletal (MSK) disorders, i.e. those not covered by specific estimates generated for RA, OA, low back pain, neck pain and gout, from 1990 to 2017 by age, sex and sociodemographic index. Methods Publicly available modelled estimates from the Global Burden of Disease (GBD) 2017 study were extracted and reported as counts and age-standardized rates per 100 000 population for 195 countries and territories between 1990 and 2017. Results Globally, the age-standardized point prevalence estimates and deaths rates of other MSK disorders in 2017 were 4151.1 and 1.0 per 100 000. This was an increase of 3.4% and 7.2%, respectively. The age-standardized DALY rate in 2017 was 380.2, an increase of 3.4%. The point prevalence estimate was higher among females and increased with age. This peaked in the 65–69 year age group for both females and males in 2017, followed by a decreasing trend for both sexes. At the national level, the highest age-standardized point prevalence estimates in 2017 were seen in Bangladesh, India and Nepal. The largest increases in age-standardized point prevalence estimates were observed in Romania, Croatia and Armenia. Conclusion The burden of other MSK disorders is proven to be substantial and increasing worldwide, with a notable intercountry variation. Data pertaining to specific diseases within this overarching category are required for future GBD MSK estimates. This would enable policymakers to better allocate resources and provide interventions appropriately. |
Databáze: | OpenAIRE |
Externí odkaz: |